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Background:  Stroke development is a major concern in patients undergoing coronary artery bypass grafting (CABG) with concomitant severe 
carotid artery stenosis (CAS). Whether synchronous carotid revascularization reduces this risk is unclear.
Methods:  A retrospective analysis of 8,595 patients who underwent isolated CABG from January 2003 to December 2009 was performed. 
Preoperative carotid duplex ultrasound was performed in 898 patients who fulfilled our preoperative guidelines. Severe CAS was identified in 117 
of these patients. Patients with severe CAS were compared to those without severe CAS to assess the rates of stroke and mortality during surgical 
hospitalization.
Results:  Patients with severe CAS were older, had a higher prevalence of hypertension, diabetes mellitus, current smokers, peripheral arterial 
disease, as well as having a previous history of stroke and congestive heart failure. Patients with severe CAS had similar rates of in-hospital stroke 
(3.3% vs. 2.7%; p=0.74) and mortality (3.4% vs. 2.8%; p=0.57) compared to patients without severe CAS. Independent predictors of in-hospital 
stroke were male sex (OR=0.54; 95% CI=0.37-0.81; p=0.002), previous history of myocardial infarction (OR=1.83; 95% CI=1.22-2.75; p=0.004), 
dyslipidemia (OR=0.60; 95% CI=0.39-0.92; p=0.02), and on-pump CABG (OR=1.66; 95% CI=1.1-2.52; p=0.02).
Conclusions:  Severe CAS alone is not a risk factor for stroke or mortality in patients undergoing CABG. The decision to perform carotid 
revascularization at the time of CABG must be individualized and based on clinical judgement. 
